Stock screenerAll disclosures →
EDGAR →
AKBA
Conviction 8HealthcareScan · Mon, Aug 10, 2026AKBA$0.8490-6.69%
ResistanceSupportVol 14Vol MA14 4.21M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.8490
Change-6.69%
Gap-1.62%
Rel volume1.42×
Avg volume3.69M
Avg $ vol4.19M
SMA 201.25
SMA 501.16
SMA 2001.42
Price vs 50-26.49%
Price vs 200-40.21%
MA stackbearish
50/200 cross—
Supertrenddown · 1.17
RSI (14)25
MACD hist-0.06
MACD cross—
Stoch %K / %D2 / 11
ADX (14)28
+DI / −DI14 / 42
RSI divergence—
MACD divergence—
ATR %+10.98%
ADR %5.72%
52w high3.42
52w low0.8490
From 52w high-75.18%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width48.97%
%B-0.15
Donchian pos2.11%
Donchian high1.42
Donchian low0.8367
AVWAP (52w high)1.67
vs AVWAP high-49.26%
AVWAP (52w low)1.11
vs AVWAP low-23.69%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d1.42×
Avg vol (14d)4.21M
Avg vol (20d)3.69M
Avg $ vol (20d)4.19M
Market cap—
RS 3m (vs SPY)-28.59%
RS 6m (vs SPY)-48.18%
RS line new highNo
Trend template0/8
Technical rank4.8
1 week-35.19%
1 month-39.36%
3 months-26.81%
6 months-38.92%
1 year-71.79%
YTD-45.23%
P/E-47.13
P/B10.07
P/S1.07
P/FCF3.72
EPS-0.0200
Div yield—
ROE-21.36%
ROA-1.53%
Debt/Eq1.98
Current1.43
EV/EBITDA5.80
Gross margin—
Net margin-2.26%
Rev growth47.46%
EPS growth92.30%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value145.93M
Revenue49.13M
Net income-8.91M
Gross profit—
Free cash flow67.7M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out268.26M
Employees194
ListedThu, Mar 20, 2014
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank4.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.41
Support1.11
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AKBA
No recent disclosed trades by Congress in AKBA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AKBA · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
ADAMS ADRIAN Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
ADAMS ADRIAN Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
Smith Cynthia Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
Smith Cynthia Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
Wolf Myles Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
FRIESON RON Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
ZUMWALT LEANNE M Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
ZUMWALT LEANNE M Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
ROGERS MICHAEL W Director · Common Stock · 2026-06-17 | Grant | 35.7K | — | 2026-06-17 | 2026-06-22 |
ROGERS MICHAEL W Director · Stock Option (Right to buy) · 2026-06-17 | Grant | 53.6K | — | 2026-06-17 | 2026-06-22 |
SEC filings
EDGAR filings in AKBA · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.